# R-(-)-Gossypol Acetic Acid in Treating Patients With Recurrent Extensive-Stage Small Cell Lung Cancer

> **NCT00773955** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 15 (actual)

## Conditions studied

- Extensive Stage Small Cell Lung Cancer
- Recurrent Small Cell Lung Cancer

## Interventions

- **DRUG:** R-(-)-gossypol acetic acid
- **OTHER:** pharmacological study
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT00773955
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2009-10
- **Final completion:** 2010-08
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2014-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00773955

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00773955, "R-(-)-Gossypol Acetic Acid in Treating Patients With Recurrent Extensive-Stage Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00773955. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*